Form 8-K - Current report:
SEC Accession No. 0001193125-25-072424
Filing Date
2025-04-03
Accepted
2025-04-03 16:50:12
Documents
27
Period of Report
2025-04-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d946200d8k.htm   iXBRL 8-K 34065
2 EX-99.1 d946200dex991.htm EX-99.1 20142
3 EX-99.2 d946200dex992.htm EX-99.2 19137
7 GRAPHIC g946200ex99_1p10g1.jpg GRAPHIC 326408
8 GRAPHIC g946200ex99_1p11g1.jpg GRAPHIC 356559
9 GRAPHIC g946200ex99_1p1g1.jpg GRAPHIC 333972
10 GRAPHIC g946200ex99_1p2g1.jpg GRAPHIC 729624
11 GRAPHIC g946200ex99_1p3g1.jpg GRAPHIC 452566
12 GRAPHIC g946200ex99_1p4g1.jpg GRAPHIC 337939
13 GRAPHIC g946200ex99_1p5g1.jpg GRAPHIC 209312
14 GRAPHIC g946200ex99_1p6g1.jpg GRAPHIC 232005
15 GRAPHIC g946200ex99_1p7g1.jpg GRAPHIC 276483
16 GRAPHIC g946200ex99_1p8g1.jpg GRAPHIC 264990
17 GRAPHIC g946200ex99_1p9g1.jpg GRAPHIC 322480
18 GRAPHIC g946200g0403093251514.jpg GRAPHIC 3763
  Complete submission text file 0001193125-25-072424.txt   5512251

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aldx-20250403.xsd EX-101.SCH 2838
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20250403_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20250403_pre.xml EX-101.PRE 11253
29 EXTRACTED XBRL INSTANCE DOCUMENT d946200d8k_htm.xml XML 3642
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 25810380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)